Background: Prolonged exposure to stress can lead to substantial suffering, impairment and societal costs. However, access to psychological treatment is limited. Internet-based cognitive behavioral therapy (ICBT) can be effective in reducing symptoms of stress, but little is known of its effects in clinical samples. The aim of this study was to investigate the efficacy of ICBT for patients suffering from chronic stress, operationalized as adjustment disorder (AD) and exhaustion disorder (ED). Methods: A total of 100 adults diagnosed with AD or ED were randomly assigned to a 12-week ICBT (n = 50) or waitlist control condition (n = 50). Primary outcome was the level of perceived stress (PSS). Secondary outcomes included several mental health symptom domains as well as functional impairment and work ability. All outcomes were assessed at baseline, after treatment and at the 6-month follow-up. The study was preregistered at Clinicaltrials.gov: NCT02540317. Results: Compared to the control condition, patients in the ICBT group made large and significant improvements on the PSS (d = 1.09) and moderate to large improvements in secondary symptom domains. Effects were maintained at the 6-month follow-up. There was no significant between-group effect on functional impairment or work ability. Conclusions: A relatively short ICBT is indicated to be effective in reducing stress-related symptoms in a clinical sample of patients with AD and ED, and has the potential to substantially increase treatment accessibility. Results must be replicated, and further research is needed to understand the relationship between symptom reduction, functional impairment and work ability.

1.
McEwen BS: Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol Rev 2007; 87: 873–904.
2.
Grossi G, Perski A, Osika W, Savic I: Stress-related exhaustion disorder – clinical manifestation of burnout? A review of assessment methods, sleep impairments, cognitive disturbances, and neuro-biological and physiological changes in clinical burnout. Scand J Psychol 2015; 56: 626–636.
3.
Kalia M: Assessing the economic impact of stress – the modern day hidden epidemic. Metabolism 2002; 51: 49–53.
4.
Henderson M, Harvey SB, Overland S, Mykletun A, Hotopf M: Work and common psychiatric disorders. J R Soc Med 2011; 104: 198–207.
5.
Van der Klink JJ, Blonk RW, Schene AH, van Dijk FJ: The benefits of interventions for work-related stress. Am J Public Health 2001; 91: 270–276.
6.
Richardson KM, Rothstein HR: Effects of occupational stress management intervention programs: a meta-analysis. J Occup Health Psychol 2008; 13: 69–93.
7.
Cavanagh K: Geographic inequity in the availability of cognitive behavioural therapy in England and Wales: a 10-year update. Behav Cogn Psychother 2014; 42: 497–501.
8.
Hedman E, Ljotsson B, Lindefors N: Cognitive behavior therapy via the Internet: a systematic review of applications, clinical efficacy and cost-effectiveness. Expert Rev Pharmacoecon Outcomes Res 2012; 12: 745–764.
9.
Heber E, Ebert DD, Lehr D, Cuijpers P, Berking M, Nobis S, Riper H: The benefit of web- and computer-based interventions for stress: a systematic review and meta-analysis. J Med Internet Res 2017; 19:e32.
10.
Heber E, Lehr D, Ebert DD, Berking M, Riper H: Web-based and mobile stress management intervention for employees: a randomized controlled trial. J Med Internet Res 2016; 18: e21.
11.
Ebert DD, Lehr D, Heber E, Riper H, Cuijpers P, Berking M: Internet- and mobile-based stress management for employees with adherence-focused guidance: efficacy and mechanism of change. Scand J Work Environ Health 2016; 42: 382–394.
12.
Persson Asplund R: Internet-based stress management for distressed managers: results from a randomised controlled trial. JMIR Res Protoc 2018; 75: 105–113.
13.
Henningsen P, Zipfel S, Sattel H, Creed F: Management of functional somatic syndromes and bodily distress. Psychother Psychosom 2018; 87: 12–31.
14.
Carta MG, Balestrieri M, Murru A, Hardoy MC: Adjustment disorder: epidemiology, diagnosis and treatment. Clin Pract Epidemiol Ment Health 2009; 5: 15.
15.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders: DSM-5. Arlington, American Psychiatric Association, 2013.
16.
Casey P: Adjustment disorder: new developments. Curr Psychiatry Rep 2014; 16: 451.
17.
World Health Organization: The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva, World Health Organization, 1992.
18.
Fava GA, Cosci F, Sonino N: Current psychosomatic practice. Psychother Psychosom 2017; 86: 13–30.
19.
Schaufeli W, Enzmann D: The Burnout Companion to Study and Practice: A Critical Analysis. Boca Raton, CRC Press, 1998.
20.
Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC: The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59(suppl 20): 22–33.
21.
Rohde P, Lewinsohn PM, Seeley JR: Comparability of telephone and face-to-face interviews in assessing axis I and II disorders. Am J Psychiatry 1997; 154: 1593–1598.
22.
Salomonsson S, Santoft F, Lindsater E, Ejeby K, Ljotsson B, Ost LG, Ingvar M, Lekander M, Hedman-Lagerlof E: Stepped care in primary care – guided self-help and face-to-face cognitive behavioural therapy for common mental disorders: a randomized controlled trial. Psychol Med 2018; 48: 1644–1654.
23.
Salomonsson S, Santoft F, Lindsater E, Ejeby K, Ljotsson B, Ost LG, Ingvar M, Lekander M, Hedman-Lagerlof E: Cognitive-behavioural therapy and return-to-work intervention for patients on sick leave due to common mental disorders: a randomised controlled trial. Occup Environ Med 2017; 74: 905–912.
24.
Morin CM, Benca R: Chronic insomnia. Lancet 2012; 379: 1129–1141.
25.
Lejuez CW, Hopko DR, Acierno R, Daughters SB, Pagoto SL: Ten year revision of the brief behavioral activation treatment for depression: revised treatment manual. Behav Modif 2011; 35: 111–161.
26.
Abramowitz JS, Deacon BJ, Whiteside SP: Exposure Therapy for Anxiety: Principles and Practice. New York, Guilford Press, 2012.
27.
Cohen S, Kamarck T, Mermelstein R: A global measure of perceived stress. J Health Soc Behav 1983; 24: 385–396.
28.
Eklund M, Backstrom M, Tuvesson H: Psychometric properties and factor structure of the Swedish version of the Perceived Stress Scale. Nord J Psychiatry 2014; 68: 494–499.
29.
Lundgren-Nilsson A, Jonsdottir IH, Pallant J, Ahlborg G Jr: Internal construct validity of the Shirom-Melamed Burnout Questionnaire (SMBQ). BMC Public Health 2012; 12: 1.
30.
Svanborg P, Åsberg M: A new self-rating scale for depression and anxiety states based on the Comprehensive Psychopathological Rating Scale. Acta Psychiatr Scand 1994; 89: 21–28.
31.
Morin CM, Savard J, Ouellet MC, Daley M: Insomnia. Wiley Online Library, 1993.
32.
Spitzer RL, Kroenke K, Williams JB, Lowe B: A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 2006; 166: 1092–1097.
33.
Andreasson AN, Wicksell R, Karshikoff B, Lodin K, Axelsson J, Höglund CO, Lekander M: Development and preliminary validation of the Sickness Questionnaire (SicknessQ). Brain Behav Immun 2013; 32:e14.
34.
Eriksson I, Unden AL, Elofsson S: Self-rated health. Comparisons between three different measures. Results from a population study. Int J Epidemiol 2001; 30: 326–333.
35.
Van Ravesteijn H, Wittkampf K, Lucassen P, van de Lisdonk E, van den Hoogen H, van Weert H, Huijser J, Schene A, van Weel C, Speckens A: Detecting somatoform disorders in primary care with the PHQ-15. Ann Fam Med 2009; 7: 232–238.
36.
Lindner P, Frykheden O, Forsstrom D, Andersson E, Ljotsson B, Hedman E, Andersson G, Carlbring P: The Brunnsviken Brief Quality of Life Scale (BBQ): development and Psychometric Evaluation. Cogn Behav Ther 2016; 45: 182–195.
37.
Axelsson E, Lindsäter E, Ljótsson B, Andersson E, Hedman-Lagerlöf E: The 12-item Self-Report World Health Organization Disability Assessment Schedule (WHODAS) 2.0 administered via the Internet to individuals with anxiety and stress disorders: a psychometric investigation based on data from two clinical trials. JMIR Ment Health 2017; 4:e58.
38.
Tuomi K, Ilmarinen J, Jahkola A, Katajarinne L, Tulkki A: Work ability index. Helsinki, Finnish Institute of Occupational Health, 1998.
39.
Borkovec TD, Nau SD: Credibility of analogue therapy rationales. J Behav Ther Exp Psychiatry 1972; 3: 257–260.
40.
Larsen DL, Attkisson CC, Hargreaves WA, Nguyen TD: Assessment of client/patient satisfaction: development of a general scale. Eval Program Plann 1979; 2: 197–207.
41.
Gueorguieva R, Krystal JH: Move over ANOVA: progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry. Arch Gen Psychiatry 2004; 61: 310–317.
42.
Jacobson NS, Truax P: Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol 1991; 59: 12–19.
43.
Lavoie JAA, Douglas KS: The Perceived Stress Scale: evaluating configural, metric and scalar invariance across mental health status and gender. J Psychopathol Behav Assess 2011; 34: 48–57.
44.
Jonsdottir IH, Hagg DA, Glise K, Ekman R: Monocyte chemotactic protein-1 (MCP-1) and growth factors called into question as markers of prolonged psychosocial stress. PLoS One 2009; 4:e7659.
45.
Glise K, Ahlborg G Jr, Jonsdottir IH: Course of mental symptoms in patients with stress-related exhaustion: does sex or age make a difference? BMC Psychiatry 2012; 12: 18.
46.
Kraemer HC, Kupfer DJ: Size of treatment effects and their importance to clinical research and practice. Biol Psychiatry 2006; 59: 990–996.
47.
Fava GA, Guidi J, Rafanelli C, Rickels K: The clinical inadequacy of the placebo model and the development of an alternative conceptual framework. Psychother Psychosom 2017; 86: 332–340.
48.
Hart T, Fann JR, Novack TA: The dilemma of the control condition in experience-based cognitive and behavioural treatment research. Neuropsychol Rehabil 2008; 18: 1–21.
49.
Andersson G: The promise and pitfalls of the Internet for cognitive behavioral therapy. BMC Med 2010; 8: 82.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.